Dysarthria and Weakness in a Patient with Cirrhosis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Mogensen J;Mogensen J; Du KN; Du KN; Hein K; Hein K; Lu LB; Lu LB
  • Source:
    Journal of general internal medicine [J Gen Intern Med] 2024 Oct; Vol. 39 (13), pp. 2590-2594. Date of Electronic Publication: 2024 Jul 12.
  • Publication Type:
    Case Reports; Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Springer Country of Publication: United States NLM ID: 8605834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1497 (Electronic) Linking ISSN: 08848734 NLM ISO Abbreviation: J Gen Intern Med Subsets: MEDLINE
    • Publication Information:
      Publication: Secaucus, NJ : Springer
      Original Publication: [Philadelphia, PA] : Hanley & Belfus, [c1986-
    • Subject Terms:
    • References:
      Shribman S, Marjot T, Sharif A, Vimalesvaran S, Ala A, Alexander G, et al. Investigation and management of Wilson’s disease: a practical guide from the British Association for the Study of the Liver. Lancet Gastroenterol Hepatol. (2022) 7(6):560–75.   https://doi.org/10.1016/s2468-1253(22)00004-8. (PMID: 10.1016/s2468-1253(22)00004-835429442)
      Lin L, Wang D, Ding N, Zheng C. Hepatic Manifestations in Wilson's Disease: Report of 110 Cases. Hepatogastroenterology. 2015 May;62(139):657-60. PMID: 26897948. (PMID: 26897948)
      Zabolotsky, Andrew MD; Frankel, Robert MD; Siddiqui, Ali MD, FACG. Wilson’s Disease Mimicking Autoimmune Hepatitis in a Patient with Fulminant Hepatic Failure: 429. American Journal of Gastroenterology 109(): p S128, October 2014. (PMID: 10.14309/00000434-201410002-00429)
      Pitre, T., Mah, J., Vertes, J. et al. Drug induced hepatitis mimicking Wilson’s disease secondary to the use of complex naturopathic regimens: a case report. BMC Gastroenterol 19, 199 (2019). https://doi.org/10.1186/s12876-019-1122-x. (PMID: 10.1186/s12876-019-1122-x317756576882359)
      Dusek P, Litwin T, Członkowska A. Neurologic impairment in Wilson disease. Ann Transl Med. 2019 Apr;7(Suppl 2): S64. https://doi.org/10.21037/atm.2019.02.43 . PMID: 31179301; PMCID: PMC6531649. (PMID: 10.21037/atm.2019.02.43.PMID:31179301311793016531649)
      Sánchez-Monteagudo A, Ripollés E, Berenguer M, Espinós C. Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease. Biomedicines. 2021 Aug 28;9(9):1100. https://doi.org/10.3390/biomedicines9091100 . PMID: 34572285; PMCID: PMC8471362. (PMID: 10.3390/biomedicines9091100345722858471362)
      Ferenci P. Hepatic encephalopathy. Gastroenterol Rep (Oxf). 2017 May;5(2):138-147. https://doi.org/10.1093/gastro/gox013 . Epub 2017 Apr 18. PMID: 28533911; PMCID: PMC5421503. (PMID: 10.1093/gastro/gox013285339115421503)
      Aggarwal A, Bhatt M. Advances in Treatment of Wilson Disease. Tremor Other Hyperkinet Mov (N Y). 2018 Feb 28; 8:525. https://doi.org/10.7916/D841881D . PMID: 29520330; PMCID: PMC5840318. (PMID: 10.7916/D841881D)
      Shribman S, Warner TT, Dooley JS. Clinical presentations of Wilson disease. Ann Transl Med. 2019 Apr;7(Suppl 2): S60. https://doi.org/10.21037/atm.2019.04.27 . PMID: 31179297; PMCID: PMC6531646. (PMID: 10.21037/atm.2019.04.27311792976531646)
      Costin BN, Miles MF. Molecular and neurologic responses to chronic alcohol use. Handb Clin Neurol. 2014; 125:157-71. https://doi.org/10.1016/B978-0-444-62619-6.00010-0 . PMID: 25307574; PMCID: PMC4412740. (PMID: 10.1016/B978-0-444-62619-6.00010-0253075744412740)
      Berry WR, Darley FL, Aronson AE. Dysarthria in Wilson's disease. J Speech Hear Res. 1974 Jun;17(2):169-83. https://doi.org/10.1044/jshr.1702.169 . PMID: 4836038. (PMID: 10.1044/jshr.1702.1694836038)
      Czlonkowska, Anna, and Michael Schilsky. “Wilson Disease: Neurologic Features.” Handbook of clinical neurology 142 (2017): 101–119. Web.
      Shaver WA, Bhatt H, Combes B. Low serum alkaline phosphatase activity in Wilson's disease. Hepatology. 1986 Sep-Oct;6(5):859-63.   https://doi.org/10.1002/hep.1840060509 . PMID: 3758940. (PMID: 10.1002/hep.18400605093758940)
      Woimant F, Debray D, Morvan E, Obadia MA, Poujois A. Efficacy and Safety of Two Salts of Trientine in the Treatment of Wilson's Disease. J Clin Med. 2022 Jul 8;11(14):3975. https://doi.org/10.3390/jcm11143975 . PMID: 35887738; PMCID: PMC9325285. (PMID: 10.3390/jcm11143975358877389325285)
      D. Gunjan, Shalimar, N. Nadda, et al. Hepatocellular carcinoma: an unusual complication of longstanding Wilson disease. J Clin Exp Hepatol, 7 (2017), pp. 152-154.
      Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson's disease: A review of what we have learned. World J Hepatol. 2015 Dec 18;7(29):2859-70.   https://doi.org/10.4254/wjh.v7.i29.2859 . PMID: 26692151; PMCID: PMC4678372. (PMID: 10.4254/wjh.v7.i29.2859266921514678372)
      Al Shamsi H, Almutairi AG, Al Mashrafi S, Al Kalbani T. Implications of Language Barriers for Healthcare: A Systematic Review. Oman Med J. 2020 Apr 30;35(2):e122.  https://doi.org/10.5001/omj.2020.40 . PMID: 32411417; PMCID: PMC7201401. (PMID: 10.5001/omj.2020.40324114177201401)
      Huwyler C, Merchant M, Jiang N. Disparities in Speech Therapy for Voice Disorders Between English- and Non-English-Speaking Patients. Laryngoscope. 2021 Jul;131(7): E2298-E2302. https://doi.org/10.1002/lary.29429 . Epub 2021 Feb 9. PMID: 33559902. (PMID: 10.1002/lary.2942933559902)
      Rooney MK, Santiago G, Perni S, Horowitz DP, McCall AR, Einstein AJ, Jagsi R, Golden DW. Readability of Patient Education Materials From High-Impact Medical Journals: A 20-Year Analysis. J Patient Exp. 2021 Mar 3;8:2374373521998847.  https://doi.org/10.1177/2374373521998847 . PMID: 34179407; PMCID: PMC8205335. (PMID: 10.1177/2374373521998847)
    • Publication Date:
      Date Created: 20240712 Date Completed: 20240927 Latest Revision: 20241029
    • Publication Date:
      20241029
    • Accession Number:
      PMC11436587
    • Accession Number:
      10.1007/s11606-024-08820-9
    • Accession Number:
      38997533